TXN
52
2
ETN
57
2
PEG
50
4
YUM
58
2
MCHP
58
11
LB
33
2
D
35
-6
GD
64
2
XRX
34
-4
NOV
55
3
LH
48
5
OXY
42
2
PG
43
-2
MHK
45
2
HAL
54
4
ESS
47
7
PVH
30
-2
HIG
70
2
HPQ
37
2
VIX
19
-6
TXN
52
2
ETN
57
2
PEG
50
4
YUM
58
2
MCHP
58
11
LB
33
2
D
35
-6
GD
64
2
XRX
34
-4
NOV
55
3
LH
48
5
OXY
42
2
PG
43
-2
MHK
45
2
HAL
54
4
ESS
47
7
PVH
30
-2
HIG
70
2
HPQ
37
2
VIX
19
-6
Financhill
Back

Marker Therapeutics, Inc. 10K Form

Buy
57

MRKR
Marker Therapeutics, Inc.

Last Price:
$1.39
Seasonality Move:
31.4%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MRKR News And Ratings

See the #1 stock for the next 7 days that we like better than MRKR

MRKR Financial Statistics

Sales & Book Value

Annual Sales: $6.6M
Cash Flow: $-2.7M
Price / Cash Flow: 0
Annual Sales: $1.10
Price / Book: 1.29

Profitability

EPS (TTM): -1.22900
Net Income (TTM): $-14.3M
Gross Margin: $0
Return on Equity: -103.04%
Return on Assets: -82.72%

Marker Therapeutics, Inc. Earnings Forecast

Key Marker Therapeutics, Inc. Financial Ratios

  • The Gross Profit Margin over the past 27 years for MRKR is 0.00%.
  • The Selling, General & Administrative Expenses for MRKR have been equal to 64.35% of Gross Profit Margin.
  • The Research & Development expenses have been 204.33% of Revenue.
  • The Net Earning history of MRKR is -162.82% of Total Revenues.
  • Per Share Earnings over the last 27 years have been positive in 17 years.

Marker Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: MRKR
CUSIP: 57055L
Website: markertherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 6.5
Quick Ratio: 5.66

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MRKR Technical Analysis vs Fundamental Analysis

Buy
57
Marker Therapeutics, Inc. (MRKR) is a Buy

Is Marker Therapeutics, Inc. a Buy or a Sell?